About: Federica Di Nicolantonio

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Federica Di Nicolantonio Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	forskare (sv) researcher (en) 연구원 (ko) গবেষক (bn) 研究者 (ja) chercheuse (fr) investigadora (es) ഗവേഷക (ml) araştırmacı (tr) дослідниця (uk) эрдэмтэн (mn) वैज्ञानिक (hi) изилдөөчү (ky) 研究者 (zh) հետազոտող (hy) onderzoeker (nl) researcher (en-ca) researcher (en-gb) researcher (en-us) hulumtuese (sq) ricercatrice (it) investigadora (ca) investigadora (gl) investigadora (pt) investigadora (ast)
rdfs:label	Federica Di Nicolantonio (en) Federica Di Nicolantonio (es) Federica Di Nicolantonio (it) Federica Di Nicolantonio (nl) Federica Di Nicolantonio (sl) Federica Di Nicolantonio (ast)
skos:prefLabel	Federica Di Nicolantonio (en) Federica Di Nicolantonio (es) Federica Di Nicolantonio (it) Federica Di Nicolantonio (nl) Federica Di Nicolantonio (sl) Federica Di Nicolantonio (ast)
name	Federica Di Nicolantonio (en) Federica Di Nicolantonio (es) Federica Di Nicolantonio (it) Federica Di Nicolantonio (nl) Federica Di Nicolantonio (sl) Federica Di Nicolantonio (ast)
Scopus author ID	wds:Q28321686-8E51D5AA-EB39-4326-826C-9CA61D8DF4FF
Scopus author ID	6603519922
given name	wds:Q28321686-D90DCFF2-BD2B-4A5A-8FB0-11579C7F97E5
given name	Federica
instance of	wds:Q28321686-5EFA4D52-00C7-4F7A-A3E4-A8277C190CA8
instance of	Homo sapiens
occupation	wds:Q28321686-3313259C-3993-42BD-BF47-EE158C1677D1
employer	wds:Q28321686-0B654D2F-1E6A-4DD5-AA87-233F4C15302B wds:Q28321686-90FBFEBC-0F59-460C-B77C-AF9188A3CEC3
sex or gender	wds:Q28321686-4FB97F3F-9D21-4984-BFB2-B471248A43B2
date of birth	wds:Q28321686-1EA41301-14BA-4118-9D44-66FFF2554A72
family name	wds:Q28321686-8078FB29-1FCB-41D1-B57B-940324348412
occupation	researcher
employer	University of Turin Candiolo Cancer Institute
sex or gender	female organism
date of birth	2000-01-01 00:00:00Z (xsd:dateTime)
family name	Di Nicolantonio
Springer Nature person ID	wds:Q28321686-44DC03C5-5DCA-42DE-A5FC-54724AE42C23
ORCID iD	wds:Q28321686-D0C85A2A-6786-419A-BF96-9614F8F586CB
Dimensions author ID	wds:Q28321686-9A6D5D5F-A1FE-4C58-B96A-66B52CA159A2
ORCID iD	https://orcid.org/0000-0001-9618-2010
Springer Nature person ID	0611102073.45
ORCID iD	0000-0001-9618-2010
Dimensions author ID	0611102073.45
Iris-AperTO author ID	wds:Q28321686-9E723471-A54C-4A46-BAC5-7C065264AAF7
Iris-AperTO author ID	02602
ResearcherID	wds:Q28321686-9C426751-D288-44C2-9D14-D72DE05045C0
Publons author ID	wds:Q28321686-416b9211-0bb2-46e0-a526-504360602aa2
ResearcherID	A-2503-2011
Publons author ID	333346
is owl:sameAs of	Federica Di Nicolantonio
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q28321686
is author of	Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer Heterogeneity of chemosensitivity of colorectal adenocarcinoma determined by a modified ex vivo ATP-tumor chemosensitivity assay (ATP-TCA). Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies. Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer. A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer Resistance to anti-EGFR therapy in colorectal cancer: from heterogeneity to convergent evolution Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model Effect of culture conditions on the chemosensitivity of ovarian cancer cell lines Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas. Cancer cell adaptation to chemotherapy. Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma Increased detection sensitivity for KRAS mutations enhances the prediction of anti-EGFR monoclonal antibody resistance in metastatic colorectal cancer.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software